The impact of the COVID-19 pandemic on the future incidence of acute lymphoblastic leukaemia in children: Projections for Germany under a COVID-19 related scenario
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
There is convincing scientific evidence that the most frequent malignancy in childhood, acute lymphoblastic leukaemia (ALL) and in particular its major subtype B-precursor ALL (BCP-ALL), is related to patterns of exposure to infectious agents in early life.1,2 Therefore, as already put forward by others,3,4 it is likely that the current COVID-19 pandemic will impact on the risk of children of developing ALL and, consequently, on the ALL incidence on a population level. The underlying infections-related model acting on the two-hit hypothesis for ALL is the one developed by Greaves.
International Journal of Cancer , éditorial, 2021